Merxin is a generic device supplier. We develop and supply inhalers “off the shelf and ready to use” to speed up finished product development. We make the world healthier, one breath at a time.
Proveris Laboratories evaluates the actual spray performance on formulation and device combination candidates. With this process the best device-formulation combination is selected by evaluating all key characteristics. The Proveris by Design™ experimental model thoroughly evaluates and documents the effect of each attribute, providing the most comprehensive insight into product performance.
Catalent combines decades of experience with all inhaled dosage forms at all stages of development including device evaluation/selection, product performance testing and dosage-form selection and technology assessment.